מערכת EpiPlex פלטפורמה - סט מלא

Bid Announcement
September 4, 2026
The following is subject to open competitive bidding.
National Research and Development Agency
National Cancer Center
Director Manno Hiroyuki
1. Items subject to competitive bidding
(1) Procurement subject and quantity
Complete set of EpiPlex platform
(2) Characteristics of the procurement subject
According to the bidding documents and specifications
(3) Delivery deadline or performance period
Until November 30, 2026 from contract conclusion date
(4) Delivery or performance location
National Cancer Center and contracted sites
(5) Bidding method
The first negotiation right holder will be decided by the lowest price bidding method,
① The bid submitted by bidders shall estimate the contract amount including direct expenses related to the procurement subject, equipment, materials, machinery, transportation costs, and all other expenses required for the outsourcing work.
② When deciding the first negotiation right holder, the bid amount plus 10% of that amount (fractions less than 1 yen shall be rounded down) will be considered the winning bid amount. Bidders must submit a bid stating 100/110 of the estimated contract amount regardless of whether they are taxable or tax-exempt businesses (excluding non-taxable transactions).
2. Qualifications required for participants
(1) Those who fall under the provisions of Articles 6 and 7 of the National Cancer Center Contract Handling Rules cannot participate.
(2) Those who have submitted false information or whose management or credit status has severely deteriorated may be excluded.
(3) Those rated A, B, C, or D in manufacturing or sales of goods with competitive qualifications in the Kanto-Koshinetsu region.
(4) Proof of a system for rapid after-sales service and maintenance related to purchased goods is required, except for service provision.
3. Location and period for contract terms and document submission
Address: 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045
National Cancer Center, Finance and Accounting Department, Procurement Division, Procurement Section 2
Bidding documents available from September 4 to September 30, 2026 (weekdays 8:30-17:00, final day until noon)
Bid submission deadline: September 30, 2026, 17:00
4. Location and date of competition execution
Location: National Cancer Center, Management Building 1F, Meeting Room 4, 5-1-1 Tsukiji, Chuo-ku, Tokyo
Date: October 1, 2026, 13:30
5. Other matters
(1) Language and currency for contract procedures: Japanese and Japanese yen.
(2) Invalid bids: Bids from ineligible participants or those failing obligations will be invalid.
(3) Contract document creation: Required.
(4) Contract decision method: The first negotiation right holder will be the bidder meeting all qualifications and requirements with the lowest price within the estimated price range.
(5) Others: Details in bidding documents.
Contact: National Cancer Center, Finance and Accounting Department, Procurement Division, Procurement Section 2, Sato
Phone: 03-3542-2511 ext. 2172
Inquiry form: https://forms.cloud.microsoft/r/TuNmFm6Gkr
Inquiries limited to matters related to this announcement.